| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/28/2011 | CA2779298A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 04/28/2011 | CA2776914A1 Diazepan derivatives as modulators of chemokine receptors |
| 04/28/2011 | CA2776480A1 Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators |
| 04/27/2011 | EP2315502A1 Electroluminescent device |
| 04/27/2011 | EP2314575A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 04/27/2011 | EP2313417A1 Angiotensin ii receptor antagonists |
| 04/27/2011 | EP2313398A1 Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof |
| 04/27/2011 | EP2313397A1 Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof |
| 04/27/2011 | EP2313396A1 Process for the preparation of high purity sunitinib and its pharmaceutically acceptable salt |
| 04/27/2011 | EP2313393A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 04/27/2011 | EP2313392A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 04/27/2011 | EP2313391A1 Isoquinolinone derivatives as nk3 antagonists |
| 04/27/2011 | EP2313375A1 Tetrahydrocinnolines as 11 beta hsd1 inhibitors for diabetes |
| 04/27/2011 | EP2313371A1 Process for preparing a 3-pyrrole substituted 2-indolinone malate salt |
| 04/27/2011 | EP2090575B1 Processes and intermediates for the preparation of N4-phenyl-quinazoline-4-amine derivatives |
| 04/27/2011 | EP2084148B1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives |
| 04/27/2011 | EP1968967B1 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators |
| 04/27/2011 | EP1824832B1 Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents |
| 04/27/2011 | EP1812112B1 Benzodiazepine derivatives as ROCK kinases inhibitors |
| 04/27/2011 | EP1477175B1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2011 | EP0934307B1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| 04/27/2011 | CN102036983A Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides |
| 04/27/2011 | CN102036981A Substituted 4-hydroxypyrimidine-5-carboxamides |
| 04/27/2011 | CN102036967A Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists |
| 04/27/2011 | CN102036963A Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors |
| 04/27/2011 | CN102036955A Hydroxamate-based inhibitors of deacetylases b |
| 04/27/2011 | CN102030741A Halogenated pyrrole-substituted 2-indolinone salt and preparation method and application thereof |
| 04/27/2011 | CN102030740A Method for preparing high-purity rizatriptan benzoate |
| 04/27/2011 | CN102030738A Novel imidazole compound, preparation method and use thereof |
| 04/27/2011 | CN101591295B Water-soluble benzopyrazolyl quaternary ammonium salt, preparation method thereof and application thereof |
| 04/27/2011 | CN101525393B Oxime ester photoinitiator and preparation method thereof |
| 04/27/2011 | CN101165057B Nbeta-substituted phenyluracil compounds for removing glass |
| 04/27/2011 | CN101033224B Novel pyrimidines small molecular compound, its preparation method and use |
| 04/26/2011 | US7932395 Substituted 1H-dihydropyrazoles, their preparation and use |
| 04/26/2011 | US7932388 Intermediates of active esters for peptide synthesis, labeling, analysis; purity |
| 04/26/2011 | US7932281 Amine-based compound and use thereof |
| 04/26/2011 | US7932277 Peptide inhibitors of hepatitis C virus replication |
| 04/26/2011 | US7932250 Thienopyrazole derivative having PDE7 inhibitory activity |
| 04/26/2011 | US7932247 M3 muscarinic acetylcholine receptor antagonists |
| 04/26/2011 | US7932246 Histone deacetylase inhibitors |
| 04/26/2011 | US7931824 Surfactants and polymerizable surfactants based on room-temperature ionic liquids that form lyotropic liquid crystal phases with water and room-temperature ionic liquids |
| 04/26/2011 | CA2634676C Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein cetp |
| 04/26/2011 | CA2612286C Substituted arylpyrazoles as parasiticidal agents |
| 04/26/2011 | CA2601458C Benzimidazolone derivatives as cb2 receptor ligands |
| 04/26/2011 | CA2583742C 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists |
| 04/26/2011 | CA2546970C Imidazole derivatives, processes for preparing them and their uses |
| 04/26/2011 | CA2508474C Pesticidal sulphonylaminopyrazoles |
| 04/26/2011 | CA2479133C 2-4-diaminopyrimidine derivatives |
| 04/26/2011 | CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 04/26/2011 | CA2467718C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/26/2011 | CA2460145C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/26/2011 | CA2447999C Caspase inhibitors and uses thereof |
| 04/26/2011 | CA2416955C Process and intermediates for preparing retroviral protease inhibitors |
| 04/21/2011 | WO2011047319A2 Antimicrobial compounds and methods of making and using the same |
| 04/21/2011 | WO2011046970A1 Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon |
| 04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | WO2011046182A1 Fluorene-containing aromatic compound, material for organic electroluminescent element, and organic electroluminescent element using same |
| 04/21/2011 | WO2011045807A2 A novel process to manufacture (2r,3s)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol |
| 04/21/2011 | WO2011045353A1 Indole and azaindole modulators of the alpha 7 nachr |
| 04/21/2011 | WO2011045292A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes |
| 04/21/2011 | WO2011045271A1 Herbicidally active, heterocyclyl-substituted pyridazinones |
| 04/21/2011 | WO2011045257A1 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions |
| 04/21/2011 | WO2011045224A1 1- (pyrid-3-yl) -pyrazole and 1- (pyrimid-5-yl) -pyrazole as pesticide |
| 04/21/2011 | WO2010144477A3 Sulfonylurea modulators of endothelin receptor |
| 04/21/2011 | WO2010141406A3 Amino pyrimidine anticancer compounds |
| 04/21/2011 | WO2010131881A3 Bifunctional organic chiral catalyst compound with superior stereoselectivity, method for preparing same, and method for preparing chiral amino acids from azlactone using same |
| 04/21/2011 | WO2010067130A8 P38 map kinase inhibitors |
| 04/21/2011 | US20110092717 Process for the preparation of high purity sunitinib and its pharmaceutically acceptable salt |
| 04/21/2011 | US20110092713 Method for producing 1-biphenylmethylimidazole compound |
| 04/21/2011 | US20110092700 Novel Coumarin Derivative Having Antitumor Activity |
| 04/21/2011 | US20110092553 Substituted Azole Derivatives, Compositions, and Methods of Use |
| 04/21/2011 | US20110092539 Indane derivatives as ampa receptor modulators |
| 04/21/2011 | US20110092512 New hsl inhibitors useful in the treatment of diabetes |
| 04/21/2011 | US20110092511 Inhibitors of akt activity |
| 04/21/2011 | US20110092501 Novel inhibitors |
| 04/21/2011 | US20110092475 2-substituted-ethynylthiazole derivatives and uses of same |
| 04/21/2011 | US20110092474 Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor |
| 04/21/2011 | US20110092415 Anti-Viral Compounds |
| 04/21/2011 | US20110091541 Preparation of formulations of angiotensin II at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 04/21/2011 | US20110091508 Oligofluorinated cross-linked polymers and uses thereof |
| 04/21/2011 | US20110091382 Novel imaging agents for detecting neurological dysfunction |
| 04/21/2011 | CA2777762A1 Amino - pyrimidine compounds as inhibitors of tbk1 and/or ikk epsilon |
| 04/21/2011 | CA2777734A1 Antimicrobial compounds and methods of making and using the same |
| 04/21/2011 | CA2777565A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | CA2776457A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes |
| 04/21/2011 | CA2774512A1 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions |
| 04/20/2011 | EP2311850A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/20/2011 | EP2311831A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/20/2011 | EP2311826A2 Novel nitrogen-containing heterocyclic compound and organic electronic device using the same |
| 04/20/2011 | EP2311825A1 Pyrimidineamines as angiogenesis modulators |
| 04/20/2011 | EP2311824A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 04/20/2011 | EP2311814A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents |
| 04/20/2011 | EP2311807A1 Compounds and composition as protein kinase inhibitors |
| 04/20/2011 | EP2311803A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/20/2011 | EP2311802A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/20/2011 | EP2311494A1 Histone modification inhibitor specific to target gene |
| 04/20/2011 | EP2310382A1 Amidophenoxyindazoles useful as inhibitors of c-met |
| 04/20/2011 | EP2310375A1 Chemical compounds |
| 04/20/2011 | EP2310373A1 Bicyclic heterocycles as mek kinase inhibitors |
| 04/20/2011 | EP2310356A1 Adamantyl diamide derivatives and uses of same |